Literature DB >> 23514048

Small cell neuroendocrine carcinoma masquerading as cellulitis and causing blindness via bilateral orbital involvement.

Alp Atik1, Matthew Krilis, Kerwin Shannon.   

Abstract

CASE REPORT: We report the first case of small cell neuroendocrine carcinoma involving both orbits and causing complete blindness. The patient was initially prescribed antibiotics for right periorbital cellulitis, but magnetic resonance imaging demonstrated abnormal enhancing tissue in the superomedial and superior right orbit with destruction of the anterior lamina papyracea, extension into the anterior ethmoid air cells, further extension into the right frontal bone and pockets of fluid in the right frontal lobe. Histopathology from the orbital tissue and right frontal subdural empyema demonstrated small cell neuroendocrine carcinoma of 'small blue cell' subtype. The patient received multidisciplinary treatment combining surgery, chemotherapy (both systemic and intra-arterial) and radiotherapy but passed away in the second year of treatment. COMMENT: Primary small cell neuroendocrine carcinoma is an extremely rare tumour, most frequently occurring in the lungs. An understanding of the pathology has been difficult, due to its rarity and the complexity of the histological diagnosis. Neuroendocrine carcinoma has a very poor prognosis and further research is required for more effective treatment options.

Entities:  

Mesh:

Year:  2013        PMID: 23514048     DOI: 10.3109/01676830.2013.772209

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  2 in total

1.  Small cell neuroendocrine carcinoma of the orbit presenting as an orbital abscess in a young female.

Authors:  Ruchi Mittal; Hrishikesh Kaza; Sunil Agarwal; Suryasnata Rath; Swarnalatha Gowrishankar
Journal:  Saudi J Ophthalmol       Date:  2018-07-27

2.  Primary neuroendocrine carcinoma of ocular adnexa.

Authors:  Daisuke Yamanouchi; Toshiyuki Oshitari; Yosuke Nakamura; Jiro Yotsukura; Kaoru Asanagi; Takayuki Baba; Tomohiro Nizawa; Takashi Kishimoto; Yoko Yonemori; Satoshi Ota; Shuichi Yamamoto
Journal:  Case Rep Ophthalmol Med       Date:  2013-11-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.